Unknown

Dataset Information

0

Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3- O -sulfated heparan sulfate.


ABSTRACT: The COVID-19 pandemic caused by SARS-CoV-2 is in immediate need of an effective antidote. Although the Spike glycoprotein (SgP) of SARS-CoV-2 has been shown to bind to heparins, the structural features of this interaction, the role of a plausible heparan sulfate proteoglycan (HSPG) receptor, and the antagonism of this pathway through small molecules remain unaddressed. Using an in vitro cellular assay, we demonstrate HSPGs modified by the 3- O -sulfotransferase isoform-3, but not isoform-5, preferentially increased SgP-mediated cell-to-cell fusion in comparison to control, unmodified, wild-type HSPGs. Computational studies support preferential recognition of the receptor-binding domain of SgP by 3- O -sulfated HS sequences. Competition with either fondaparinux, a 3- O -sulfated HS-binding oligopeptide, or a synthetic, non-sugar small molecule, blocked SgP-mediated cell-to-cell fusion. Finally, the synthetic, sulfated molecule inhibited fusion of GFP-tagged pseudo SARS-CoV-2 with human 293T cells with sub-micromolar potency. Overall, overexpression of 3- O -sulfated HSPGs contribute to fusion of SARS-CoV-2, which could be effectively antagonized by a synthetic, small molecule.

SUBMITTER: Tiwari V 

PROVIDER: S-EPMC7553162 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-<i>O</i>-sulfated heparan sulfate.

Tiwari Vaibhav V   Tandon Ritesh R   Sankaranarayanan Nehru Viji NV   Beer Jacob C JC   Kohlmeir Ellen K EK   Swanson-Mungerson Michelle M   Desai Umesh R UR  

bioRxiv : the preprint server for biology 20201008


The COVID-19 pandemic caused by SARS-CoV-2 is in immediate need of an effective antidote. Although the Spike glycoprotein (SgP) of SARS-CoV-2 has been shown to bind to heparins, the structural features of this interaction, the role of a plausible heparan sulfate proteoglycan (HSPG) receptor, and the antagonism of this pathway through small molecules remain unaddressed. Using an <i>in vitro</i> cellular assay, we demonstrate HSPGs modified by the 3-<i>O</i>-sulfotransferase isoform-3, but not iso  ...[more]

Similar Datasets

| S-EPMC8525342 | biostudies-literature
| S-EPMC9016215 | biostudies-literature
| S-SCDT-10_15252-EMBR_202357224 | biostudies-other
| S-EPMC8553634 | biostudies-literature
| S-EPMC9136977 | biostudies-literature
| S-EPMC8227597 | biostudies-literature
| S-EPMC8308704 | biostudies-literature
| S-EPMC8892577 | biostudies-literature
| S-EPMC10082822 | biostudies-literature
| S-EPMC8581954 | biostudies-literature